SCHEDULE 13D/A

Candel Therapeutics Inc

Common Stock, $0.01 par value per share · CUSIP: 137404109

Event date: 2024-12-16

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Paul B ManningReported CIK 0001494695

  Shares: 5,790,999.00 · Class: 7.9%

• The Paul B. Manning Revocable Trust dated May 10, 2000

  Shares: 2,763,527.00 · Class: 3.8%

• BKB Growth Investments, LLC

  Shares: 1,303,752.00 · Class: 1.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.